<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Alfino LN</submitter><funding>NCATS NIH HHS</funding><funding>NIH Office of the Director</funding><funding>NIH HHS</funding><pagination>981-993</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8426451</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>58(5)</volume><pubmed_abstract>Periostin is a matricellular protein important in regulating bone, tooth, and cardiac development. In pathologic conditions, periostin drives allergic and fibrotic inflammatory diseases and is also overexpressed in certain cancers. Periostin signaling in tumors has been shown to promote angiogenesis, metastasis, and cancer stem cell survival in rodent models, and its overexpression is associated with poor prognosis in human glioblastoma. However, the role of periostin in regulating tumorigenesis of canine cancers has not been evaluated. Given its role in bone development, we sought to evaluate mRNA and protein expression of periostin in canine osteosarcoma (OS) and assess its association with patient outcome. We validated an anti-human periostin antibody cross-reactive to canine periostin </pubmed_abstract><journal>Veterinary pathology</journal><pubmed_title>Role of Periostin Expression in Canine Osteosarcoma Biology and Clinical Outcome.</pubmed_title><pmcid>PMC8426451</pmcid><funding_grant_id>K01 OD022982</funding_grant_id><funding_grant_id>R03 OD028265</funding_grant_id><funding_grant_id>1R03OD028265</funding_grant_id><funding_grant_id>L30 TR002126</funding_grant_id><funding_grant_id>T35 OD015130</funding_grant_id><pubmed_authors>Coy J</pubmed_authors><pubmed_authors>Ehrhart EJ</pubmed_authors><pubmed_authors>Duval DL</pubmed_authors><pubmed_authors>Wilczewski-Shirai KC</pubmed_authors><pubmed_authors>Glapa K</pubmed_authors><pubmed_authors>Charles JB</pubmed_authors><pubmed_authors>Regan DP</pubmed_authors><pubmed_authors>Alfino LN</pubmed_authors><pubmed_authors>Cronise KE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Role of Periostin Expression in Canine Osteosarcoma Biology and Clinical Outcome.</name><description>Periostin is a matricellular protein important in regulating bone, tooth, and cardiac development. In pathologic conditions, periostin drives allergic and fibrotic inflammatory diseases and is also overexpressed in certain cancers. Periostin signaling in tumors has been shown to promote angiogenesis, metastasis, and cancer stem cell survival in rodent models, and its overexpression is associated with poor prognosis in human glioblastoma. However, the role of periostin in regulating tumorigenesis of canine cancers has not been evaluated. Given its role in bone development, we sought to evaluate mRNA and protein expression of periostin in canine osteosarcoma (OS) and assess its association with patient outcome. We validated an anti-human periostin antibody cross-reactive to canine periostin </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-04T09:37:36.256Z</modification><creation>2025-04-04T09:37:36.256Z</creation></dates><accession>S-EPMC8426451</accession><cross_references><pubmed>33685296</pubmed><doi>10.1177/0300985821996671</doi></cross_references></HashMap>